248 results on '"Nero, Tracy L."'
Search Results
2. Cytokine Receptors and Their Ligands
3. Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia
4. Shear-Sensing by C-Reactive Protein: Linking Aortic Stenosis and Inflammation.
5. Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma.
6. Structural biology of cell surface receptors implicated in Alzheimer’s disease
7. Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms
8. Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis
9. Figure S7 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
10. Supplementary Table S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
11. Data from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
12. Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
13. Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
14. Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
15. Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9
16. A novel phosphocholine‐mimetic inhibits a pro‐inflammatory conformational change in C‐reactive protein
17. C-reactive protein, immunothrombosis and venous thromboembolism
18. EPO does not promote interaction between the erythropoietin and beta-common receptors
19. Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription
20. Signalling by the βc family of cytokines
21. Characterization of pathogenic human monoclonal autoantibodies against GM-CSF
22. Transitional Changes in the Structure of C-Reactive Protein Create Highly Pro-Inflammatory Molecules: Therapeutic Implications for Cardiovascular Diseases
23. Oncogenic protein interfaces: small molecules, big challenges
24. A novel phosphocholine‐mimetic inhibits a pro‐inflammatory conformational change in C‐reactive protein.
25. Structural biology of cell surface receptors implicated in Alzheimer’s disease
26. The βc receptor family – Structural insights and their functional implications
27. Messing with βc: A unique receptor with many goals
28. Repurposing of drugs as STAT3 inhibitors for cancer therapy
29. PEGylation of a proprotein convertase peptide inhibitor for vaginal route of drug delivery: In vitro bioactivity, stability and in vivo pharmacokinetics
30. Role of β-Adrenergic Receptor Subtypes in Lipolysis
31. The GM–CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling
32. Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments
33. Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
34. A family of dual-activity glycosyltransferasesphosphorylases mediates mannogen turnover and virulence in Leishmania parasites
35. Agonist binding and activation of the rat β1-adrenergic receptor: role of Trp134 (3.28), Ser190 (4.57) and Tyr356 (7.43)
36. A Family of Dual-Activity Glycosyltransferase-Phosphorylases Mediates Mannogen Turnover and Virulence in Leishmania Parasites
37. Evolution of a New Pathway of Reserve Carbohydrate Biosynthesis in Leishmania Parasites
38. Synthesis, β-adrenoceptor pharmacology and toxicology of S-(−)-1-(4-(2-ethoxyethoxy)phenoxy)-2-hydroxy-3-(2-(3,4-dimethoxyphenyl)ethylamino)propane hydrochloride, a short acting β 1-specific antagonist
39. CoMFA analysis of the human β 1-adrenoceptor binding affinity of a series of phenoxypropanolamines
40. Protein structure and computational drug discovery
41. The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities
42. A dual role for the N-terminal domain of the IL-3 receptor in cell signalling
43. β 1- and β 2-Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines
44. Role of the β Common (βc) Family of Cytokines in Health and Disease
45. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites
46. Conformational Changes in the GM-CSF Receptor Suggest a Molecular Mechanism for Affinity Conversion and Receptor Signaling
47. Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
48. Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
49. Unexpected mechanisms of action for a cytokine receptor-blocking antibody
50. 17
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.